VOCSN: ‘Not just another ventilator’

 - 
Friday, April 14, 2017

BOTHELL, Wash. – Ventec Life Systems has received FDA 510(k) clearance of its VOCSN, a unified respiratory systems for ventilator patients. VOCSN combines five respiratory therapies—ventilation, oxygen, cough, suction and nebulization—and is designed to improve care for patients with neuromuscular disease, impaired lung function, spinal cord injury and pediatric development complications. The system is designed for use in hospital institutional, transport and home settings, and enables caregivers to spend less time managing machines and more time caring for patients. “I’ve seen firsthand how improved ventilator technology can enhance the quality of life for patients and caregivers,” said Doug DeVries, founder and CEO of Ventec, in a press release. “Our team didn’t want to create just another ventilator, we spent the past five years focused on building a truly integrated solution.”